WEST LAFAYETTE – Purdue University and Indiana University Health Arnett have announced a joint clinical research study on colorectal cancer, focused on broadening participating from patients in more rural parts of the state.
Research teams from the two universities are working with colorectal cancer data to develop tools for helping improve prevention, treatment and care of those with cancer.
“This is another terrific example of how great things can happen when IU, Purdue and the private sector collaborate on a major challenge facing our world – in this case, colorectal cancer,” said Vic Lechtenberg, acting executive vice president for academic affairs and provost at Purdue. “This partnership between IU Health Arnett and Purdue widens the bridge for our scientists and clinicians.”
Dr. Wael Harb, director of Oncology and Research for IU Health Arnett in Lafayette, said, “Cancer won’t be eradicated in a single laboratory by an individual researcher. We all must come together to assist the research that’s being done to give doctors the tools they need to better diagnose and treat cancer.”
The research will involve 100 cancer patients and is being funded through a $5 million grant from the U.S. Department of Defense, the Walther Cancer Foundation and the Regenstrief Foundation.